MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

Through our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or Agency) that may affect ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

Karnataka issues order to merge Ayush drug dept with State FDA: Nandita Vijayasimha, Bengaluru Friday, August 1, 2025, 08:00 Hrs [IST] Karnataka government has issued order on the ...

The Expanded Decision Tree chemical toxicity and risk screening tool was evaluated through external peer-review, and FDA will ...

Formulated with AMPK-activating botanicals and GLUT-4 support compounds, Glucorem explores how non-stimulant glucose ...

U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...

Three more outbreaks were reported, bringing the year's total to 32, double the number reported for all of 2024.

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...

A longitudinal study at Johns Hopkins that began in 1995 depends on the dedication of hundreds of people as well as NIH ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...